Autres langues Bluejay Diagnostics, Inc.

Actions

BJDX

US0956334009

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
0,5709 ^USD	-0,37 %		-10,78 %	-94,15 %

28/06	Bluejay Diagnostics clôture un appel public à l'épargne de 8,8 millions de dollars	MT
27/06	Les plus fortes baisses du jour	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bluejay Diagnostics Closes $8.8 Million Public Offering	28/06
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering	28/06
Top Midday Decliners	27/06
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	27/06
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering	27/06
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data	27/06
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients	26/06
Buejay Diagnostics, Inc Announces Results from the Primary Analysis of SYMON-I	26/06
Bluejay Diagnostics Announces Reverse Stock Split	17/06
Bluejay Diagnostics, Inc. announced a financing transaction	31/05
Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Bluejay Diagnostics, Inc. Appoints Neil Dey as Principal Financial and Accounting Officer	02/04
Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering	02/01
Top Premarket Decliners	28/12
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering	28/12
Top Midday Decliners	27/12
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients	27/12
Bluejay Diagnostics Starts Clinical Study of Symphony IL-6 Test in Sepsis Patients; Shares Fall	27/12
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)	27/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bluejay Diagnostics, Inc.

Actions

BJDX

US0956334009

Autres langues

Filtres